|
|
|
Insider
Information: |
Kerins Patrick J |
Relationship: |
10% Owner |
City: |
Baltimore |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
36 |
|
Direct
Shares |
2,400,049 |
|
Indirect Shares
|
216,112,072 |
|
|
Direct
Value |
$2,847,453 |
|
|
Indirect Value
|
$648,220,632 |
|
|
Total
Shares |
218,512,121 |
|
|
Total
Value |
$651,068,085 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-59.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Hemosense Inc |
HEM |
10% Owner |
2006-12-12 |
1,772,151 |
|
0 |
Premium* |
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
|
0 |
2011-03-10 |
0 |
Premium* |
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-28 |
97 |
2012-02-28 |
0 |
Premium* |
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2010-06-30 |
0 |
2014-08-29 |
4,659,333 |
Premium* |
|
Groupon, Inc. |
GRPN |
10% Owner |
2013-09-13 |
7,944 |
2013-09-13 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-03 |
575 |
2013-06-03 |
0 |
Premium* |
|
Millennial Media Inc |
MM |
Director |
2015-10-22 |
15,625 |
2015-10-22 |
0 |
Premium* |
|
Tesaro, Inc. |
TSRO |
10% Owner |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
2015-05-07 |
0 |
2015-05-07 |
0 |
Premium* |
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-10 |
1,730 |
2013-04-10 |
0 |
Premium* |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Channeladvisor Corp |
ECOM |
Director |
2016-03-01 |
35,853 |
2015-12-14 |
0 |
Premium* |
|
Epizyme, Inc. |
EPZM |
10% Owner |
2016-01-12 |
651 |
2016-01-12 |
6,260,851 |
Premium* |
|
Care.com Inc |
CRCM |
10% Owner |
2017-11-06 |
504 |
2017-11-06 |
0 |
Premium* |
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
2020-06-10 |
11,324 |
2020-06-10 |
0 |
Premium* |
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2018-09-07 |
82,978,668 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
3,594 |
2020-09-14 |
0 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
1,523 |
2018-02-13 |
0 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
|
0 |
2019-10-30 |
5,925,287 |
Premium* |
|
Cloudflare, Inc. |
NET |
10% Owner |
2020-11-11 |
203,454 |
2020-11-11 |
0 |
Premium* |
|
Sprout Social, Inc. |
SPT |
10% Owner |
2020-11-13 |
38,644 |
2020-11-13 |
0 |
Premium* |
|
Coursera, Inc. |
COUR |
10% Owner |
2021-05-19 |
70,394 |
2021-05-19 |
0 |
Premium* |
|
BuzzFeed, Inc |
BZFD |
Director, 10% Owner |
2023-12-03 |
222,847 |
2023-12-03 |
15,333,892 |
Premium* |
|
Sagimet Biosciences Inc. |
SGMT |
10% Owner |
2024-01-29 |
13,139 |
2024-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
217 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LOXO |
Loxo Oncology, Inc. |
10% Owner |
|
2014-08-06 |
4 |
B |
$13.00 |
$2,999,997 |
I/I |
230,769 |
1,789,420 |
1.5 |
- |
|
LOXO |
Loxo Oncology, Inc. |
10% Owner |
|
2014-08-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,558,651 |
1,558,651 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
|
2014-08-08 |
4 |
S |
$6.62 |
$4,468,568 |
I/I |
(675,000) |
4,961,573 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
|
2014-08-12 |
4 |
S |
$6.76 |
$240,190 |
I/I |
(35,540) |
4,926,033 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
10% Owner |
|
2014-08-14 |
4 |
A |
$0.00 |
$0 |
I/I |
12,900 |
12,900 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
10% Owner |
|
2014-08-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,302,900) |
0 |
0 |
- |
|
EPZM |
Epizyme, Inc. |
10% Owner |
|
2014-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
651 |
651 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
|
2014-08-27 |
4 |
S |
$8.17 |
$884,811 |
I/I |
(108,300) |
4,817,733 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
|
2014-08-28 |
4 |
S |
$7.87 |
$1,154,846 |
I/I |
(146,800) |
4,670,933 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
|
2014-08-29 |
4 |
S |
$7.51 |
$87,070 |
I/I |
(11,600) |
4,659,333 |
0 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2014-12-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
0 |
- |
|
ILIU |
Interleukin Genetics Inc |
10% Owner |
|
2014-12-23 |
4 |
B |
$0.10 |
$1,992,857 |
I/I |
19,868,965 |
35,298,087 |
1.5 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2014-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
241 |
241 |
0 |
- |
|
BOX |
Box Inc |
10% Owner |
|
2015-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
162,780 |
|
- |
|
BOX |
Box Inc |
10% Owner |
|
2015-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,928,677 |
2,091,457 |
0 |
- |
|
BOX |
Box Inc |
10% Owner |
|
2015-01-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,091,457) |
0 |
0 |
- |
|
TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
|
2015-02-04 |
4 |
B |
$10.00 |
$5,000,000 |
I/I |
500,000 |
1,888,474 |
1.5 |
- |
|
TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
|
2015-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,388,474 |
1,388,474 |
0 |
- |
|
CSBR |
Champions Biotechnology I... |
10% Owner |
|
2015-03-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,750,000 |
|
- |
|
HPTX |
Hyperion Therapeutics Inc |
10% Owner |
|
2015-05-07 |
4 |
D |
$46.00 |
$5,520 |
D/D |
(120) |
0 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
10% Owner |
|
2015-05-07 |
4 |
D |
$46.00 |
$109,674,166 |
I/I |
(2,384,221) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
10% Owner |
|
2015-06-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,010,000) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
10% Owner |
|
2015-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
10% Owner |
|
2015-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
504 |
1,333 |
0 |
- |
|
ARDX |
Ardelyx Inc |
10% Owner |
|
2015-06-05 |
4 |
B |
$10.70 |
$20,000,001 |
I/I |
1,869,159 |
7,488,893 |
1.5 |
- |
|
217 Records found
|
|
Page 3 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|